Can this patient avoid further treatment?
A 72-year-old Caucasian male presents with primary SCC of the central forehead.
Case details
The patient's lesion, located on his forehead, was 2.8 x 1.5 cm. The patient has type 2 diabetes, hypertension, renal cell carcinoma s/p right nephrectomy.
- Post-operative adjuvant radiation therapy.
Why DecisionDx-SCC?
Post-operative radiation therapy considered due to the high-risk features of large size and tumor depth> 4 mm. The patient wished to avoid further treatment if possible.
Test result
In this patient, the DecisionDx-SCC test result of Class 2A indicates a higher biological risk for metastasis (38.6%). This assisted the clinician in deciding to proceed with the treatment pathway – ART treatment 5 months post-initial surgery to decrease chance of recurrence or metastasis.
The DecisionDx-SCC test result of Class 2A indicates a higher biological risk for metastasis (38.6%). This assisted the clinician in deciding to proceed with the treatment pathway – ART treatment 5 months post-initial surgery to decrease chance of recurrence or metastasis.
DecisionDx-SCC testing provided valuable objective information and helped determined that the patient should proceed with the ART treatment.
